Renaissance Technologies LLC Purchases 40,946 Shares of LENSAR, Inc. (NASDAQ:LNSR)

Renaissance Technologies LLC raised its stake in LENSAR, Inc. (NASDAQ:LNSR - Free Report) by 13.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 348,891 shares of the company's stock after acquiring an additional 40,946 shares during the quarter. Renaissance Technologies LLC owned about 3.01% of LENSAR worth $3,119,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Evernest Financial Advisors LLC bought a new position in LENSAR in the 4th quarter valued at about $174,000. Bailard Inc. acquired a new position in shares of LENSAR during the 4th quarter worth approximately $181,000. Atria Investments Inc grew its position in shares of LENSAR by 28.2% during the 4th quarter. Atria Investments Inc now owns 26,055 shares of the company's stock worth $233,000 after purchasing an additional 5,729 shares in the last quarter. Essex Investment Management Co. LLC grew its position in shares of LENSAR by 18.3% during the 4th quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock worth $357,000 after purchasing an additional 6,184 shares in the last quarter. Finally, Geode Capital Management LLC grew its position in shares of LENSAR by 3.5% during the 3rd quarter. Geode Capital Management LLC now owns 100,431 shares of the company's stock worth $460,000 after purchasing an additional 3,423 shares in the last quarter. 40.15% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on LNSR. BTIG Research lowered shares of LENSAR from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 24th. Lake Street Capital reiterated a "hold" rating and set a $15.00 price target (down previously from $16.00) on shares of LENSAR in a research report on Monday, March 24th.

LENSAR Stock Performance

LENSAR stock remained flat at $14.03 during mid-day trading on Tuesday. 16,465 shares of the company's stock were exchanged, compared to its average volume of 71,598. LENSAR, Inc. has a 1 year low of $2.95 and a 1 year high of $17.31. The firm has a market cap of $165.40 million, a P/E ratio of -9.61 and a beta of 0.56. The company has a fifty day moving average of $13.62 and a two-hundred day moving average of $9.98.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported ($1.61) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($1.40). LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%. The company had revenue of $16.73 million during the quarter, compared to the consensus estimate of $14.95 million.

LENSAR Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.